Insulet Return on Tangible Equity 2010-2025 | PODD
Current and historical return on tangible equity values for Insulet (PODD) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Insulet Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-06-30 | $0.24B | $1.31B | 20.99% |
| 2025-03-31 | $0.40B | $1.18B | 39.74% |
| 2024-12-31 | $0.42B | $1.06B | 47.77% |
| 2024-09-30 | $0.42B | $0.97B | 55.58% |
| 2024-06-30 | $0.40B | $0.85B | 62.71% |
| 2024-03-31 | $0.23B | $0.64B | 44.98% |
| 2023-12-31 | $0.21B | $0.58B | 45.98% |
| 2023-09-30 | $0.12B | $0.46B | 30.79% |
| 2023-06-30 | $0.06B | $0.40B | 17.67% |
| 2023-03-31 | $0.00B | $0.35B | 0.30% |
| 2022-12-31 | $0.00B | $0.35B | 1.50% |
| 2022-09-30 | $0.02B | $0.32B | 4.66% |
| 2022-06-30 | $0.04B | $0.32B | 8.99% |
| 2022-03-31 | $0.05B | $0.34B | 11.05% |
| 2021-09-30 | $-0.03B | $0.42B | -6.24% |
| 2021-06-30 | $-0.03B | $0.39B | -6.05% |
| 2020-12-31 | $0.01B | $0.54B | 1.75% |
| 2020-09-30 | $0.03B | $0.55B | 10.66% |
| 2020-06-30 | $0.02B | $0.51B | 11.23% |
| 2020-03-31 | $0.01B | $0.01B | 6.15% |
| 2019-12-31 | $0.01B | $0.02B | 8.98% |
| 2019-09-30 | $0.02B | $0.10B | 10.17% |
| 2019-06-30 | $0.02B | $0.20B | 9.99% |
| 2019-03-31 | $0.01B | $0.17B | 9.06% |
| 2018-12-31 | $0.00B | $0.16B | 2.10% |
| 2018-09-30 | $-0.01B | $0.15B | -10.69% |
| 2018-06-30 | $-0.02B | $0.13B | -17.82% |
| 2018-03-31 | $-0.02B | $0.13B | -32.88% |
| 2017-12-31 | $-0.03B | $0.11B | -57.45% |
| 2017-09-30 | $-0.03B | $0.03B | -122.11% |
| 2017-06-30 | $-0.03B | $0.02B | -133.33% |
| 2017-03-31 | $-0.03B | $0.02B | -189.09% |
| 2016-12-31 | $-0.03B | $0.02B | -589.47% |
| 2016-09-30 | $-0.05B | $0.03B | 2300.00% |
| 2016-06-30 | $-0.06B | $-0.01B | 800.00% |
| 2016-03-31 | $-0.07B | $-0.01B | -14600.00% |
| 2015-12-31 | $-0.07B | $-0.01B | -634.78% |
| 2015-09-30 | $-0.05B | $0.00B | -242.86% |
| 2015-06-30 | $-0.04B | $0.02B | -156.36% |
| 2015-03-31 | $-0.06B | $0.03B | -200.00% |
| 2014-12-31 | $-0.05B | $0.03B | -134.21% |
| 2014-09-30 | $-0.05B | $0.03B | -103.70% |
| 2014-06-30 | $-0.06B | $0.02B | -104.42% |
| 2014-03-31 | $-0.04B | $0.07B | -57.95% |
| 2013-12-31 | $-0.05B | $0.07B | -64.56% |
| 2013-09-30 | $-0.05B | $0.07B | -106.00% |
| 2013-06-30 | $-0.04B | $0.08B | -141.94% |
| 2013-03-31 | $-0.05B | $0.07B | -482.05% |
| 2012-12-31 | $-0.05B | $-0.02B | 784.62% |
| 2012-09-30 | $-0.06B | $-0.01B | -3666.67% |
| 2012-06-30 | $-0.06B | $0.00B | -518.18% |
| 2012-03-31 | $-0.05B | $0.01B | -245.78% |
| 2011-12-31 | $-0.05B | $0.02B | -133.33% |
| 2011-09-30 | $-0.05B | $0.03B | -112.77% |
| 2011-06-30 | $-0.05B | $0.04B | -104.62% |
| 2011-03-31 | $-0.06B | $0.06B | -111.76% |
| 2010-12-31 | $-0.06B | $0.07B | -131.89% |
| 2010-09-30 | $-0.06B | $0.03B | -123.76% |
| 2010-06-30 | $-0.06B | $0.04B | -165.99% |
| 2010-03-31 | $-0.07B | $0.04B | -268.00% |
| 2009-12-31 | $-0.07B | $0.06B | -394.59% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $23.078B | $2.072B |
| Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.741B | 26.94 |
| Boston Scientific (BSX) | United States | $155.895B | 37.18 |
| Stryker (SYK) | United States | $147.123B | 29.95 |
| EssilorLuxottica (ESLOY) | France | $145.891B | 0.00 |
| Medtronic (MDT) | Ireland | $116.772B | 16.47 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.160B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.031B | 25.15 |
| ResMed (RMD) | United States | $42.217B | 30.19 |
| GE HealthCare Technologies (GEHC) | United States | $33.398B | 15.70 |
| Agilent Technologies (A) | United States | $33.278B | 21.69 |
| Terumo (TRUMY) | Japan | $27.302B | 32.35 |
| Koninklijke Philips (PHG) | Netherlands | $26.423B | 17.48 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.685B | 13.17 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.192B | 0.00 |
| Baxter (BAX) | United States | $12.250B | 9.46 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.714B | 28.33 |
| Lantheus Holdings (LNTH) | United States | $4.023B | 10.88 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.400B | 23.79 |
| Perrigo (PRGO) | Ireland | $3.224B | 8.05 |
| Prestige Consumer Healthcare (PBH) | United States | $3.221B | 14.29 |
| ICU Medical (ICUI) | United States | $3.005B | 20.46 |
| Haemonetics (HAE) | United States | $2.601B | 11.61 |
| LeMaitre Vascular (LMAT) | United States | $2.183B | 46.82 |
| Acuren (TIC) | United States | $2.054B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.918B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.804B | 77.48 |
| AtriCure (ATRC) | United States | $1.776B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.742B | 10.97 |
| Phibro Animal Health (PAHC) | United States | $1.279B | 16.35 |
| AdaptHealth (AHCO) | United States | $1.261B | 17.92 |
| Tilray Brands (TLRY) | Canada | $1.222B | 0.00 |
| Neogen (NEOG) | United States | $1.216B | 19.31 |
| BioLife Solutions (BLFS) | United States | $1.201B | 2508.00 |
| Valneva SE (VALN) | France | $0.952B | 0.00 |
| InMode (INMD) | Israel | $0.898B | 8.31 |
| Kestra Medical Technologies (KMTS) | United States | $0.876B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.622B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.609B | 0.00 |
| SNDL (SNDL) | Canada | $0.589B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.587B | 0.00 |
| ZimVie (ZIMV) | United States | $0.534B | 20.58 |
| Surmodics (SRDX) | United States | $0.516B | 0.00 |
| Evolus (EOLS) | United States | $0.480B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.471B | 16.20 |
| CeriBell (CBLL) | United States | $0.428B | 0.00 |
| Owens & Minor (OMI) | United States | $0.392B | 3.48 |
| Sanuwave Health (SNWV) | United States | $0.354B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.321B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Omeros (OMER) | United States | $0.305B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.303B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.297B | 0.00 |
| Brainsway (BWAY) | Israel | $0.283B | 57.65 |
| Viemed Healthcare (VMD) | United States | $0.273B | 20.74 |
| High Tide (HITI) | Canada | $0.273B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.272B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.270B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.231B | 0.00 |
| Cerus (CERS) | United States | $0.230B | 0.00 |
| Quanterix (QTRX) | United States | $0.225B | 0.00 |
| Exagen (XGN) | United States | $0.220B | 0.00 |
| Organigram Global (OGI) | Canada | $0.210B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.209B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.184B | 15.37 |
| FitLife Brands (FTLF) | United States | $0.155B | 19.10 |
| Biote (BTMD) | United States | $0.149B | 4.95 |
| Jushi Holdings (JUSHF) | United States | $0.131B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.17 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| MacroGenics (MGNX) | United States | $0.091B | 0.00 |
| Jin Medical (ZJYL) | China | $0.089B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.084B | 0.00 |
| Apyx Medical (APYX) | United States | $0.078B | 0.00 |
| Safety Shot (SHOT) | United States | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.054B | 31.47 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| Veru (VERU) | United States | $0.052B | 0.00 |
| Zynex (ZYXI) | United States | $0.046B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 33.50 |
| Rockwell Medical (RMTI) | United States | $0.040B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 14.82 |
| Trinity Biotech (TRIB) | Ireland | $0.028B | 0.00 |
| Senestech (SNES) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |